S. KARABULUT Et Al. , "Clinical significance of serum protein and mRNA level of insulin-like growth factor-1 (IGF-1) in patients with hepatocellular carcinoma," Gastrointestinal Cancers Symposium , vol.32, San-Francisco, Costa Rica, 2014
KARABULUT, S. Et Al. 2014. Clinical significance of serum protein and mRNA level of insulin-like growth factor-1 (IGF-1) in patients with hepatocellular carcinoma. Gastrointestinal Cancers Symposium , (San-Francisco, Costa Rica).
KARABULUT, S., Aykan, N. F., Yildiz, İ., Kilic, L., Sen, F., & VATANSEVER, S., (2014). Clinical significance of serum protein and mRNA level of insulin-like growth factor-1 (IGF-1) in patients with hepatocellular carcinoma . Gastrointestinal Cancers Symposium, San-Francisco, Costa Rica
KARABULUT, Senem Et Al. "Clinical significance of serum protein and mRNA level of insulin-like growth factor-1 (IGF-1) in patients with hepatocellular carcinoma," Gastrointestinal Cancers Symposium, San-Francisco, Costa Rica, 2014
KARABULUT, Senem Et Al. "Clinical significance of serum protein and mRNA level of insulin-like growth factor-1 (IGF-1) in patients with hepatocellular carcinoma." Gastrointestinal Cancers Symposium , San-Francisco, Costa Rica, 2014
KARABULUT, S. Et Al. (2014) . "Clinical significance of serum protein and mRNA level of insulin-like growth factor-1 (IGF-1) in patients with hepatocellular carcinoma." Gastrointestinal Cancers Symposium , San-Francisco, Costa Rica.
@conferencepaper{conferencepaper, author={Senem KARABULUT Et Al. }, title={Clinical significance of serum protein and mRNA level of insulin-like growth factor-1 (IGF-1) in patients with hepatocellular carcinoma}, congress name={Gastrointestinal Cancers Symposium}, city={San-Francisco}, country={Costa Rica}, year={2014}}